Glucosamine associated with faster progression from mild cognitive impairment to dementia

University of Florida researchers, in Nature Metabolism, linked glucosamine to a 25% higher likelihood that mild cognitive impairment would advance to dementia in a large retrospective health-record study, with lab work in human brain tissue and Alzheimer’s mouse models. Results are preliminary; clinical trials are needed to establish whether the joint supplement causes harm.